Expertise in
3
conditions

Nathalie Massin

University Paris Est, 
Creteil, FR 
Expertise in
3
conditions
University Paris Est, 
Creteil, FR 

Overview

Nathalie Massin practices practicing medicine in Creteil, France.

Ms. Massin is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Ovarian Hyperstimulation Syndrome, Infertility, Midline Cleft of Lower Lip, Persistent Mullerian Duct Syndrome, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

University Paris Est, Creteil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa in Women Older Than 38 Years Old Undergoing in Vitro Fertilization
Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa in Women Older Than 38 Years Old Undergoing in Vitro Fertilization
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drug: Estrogens
Study Phase: Phase 3
Comparison of the Cumulative Number of Oocytes Obtained With 2 Controlled Ovarian Hyperstimulations (COH) Within the Same Cycle With FertistartKit® (DUOSTIM) Versus 2 Conventional COH in Poor Ovarian Responders Undergoing IVF. Bistim Study
Comparison of the Cumulative Number of Oocytes Obtained With 2 Controlled Ovarian Hyperstimulations (COH) Within the Same Cycle With FertistartKit® (DUOSTIM) Versus 2 Conventional COH in Poor Ovarian Responders Undergoing IVF. Bistim Study
Enrollment Status: Completed
Publish Date: December 07, 2022
Intervention Type: Drug
Study Phase: Phase 3
Phase III Trial to Assess Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI Outcomes in Infertile Women Presenting With Adenomyosis.
Phase III Trial to Assess Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI Outcomes in Infertile Women Presenting With Adenomyosis.
Enrollment Status: Withdrawn
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drugs: GnRH agonist, Estradiol
Study Phase: Phase 3
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Enrollment Status: Terminated
Publish Date: July 15, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Comparison of the Number of Visits and the Quality of Life Versus Natural Cycle in Stimulated Cycle Before Frozen Embryo Transfer
Comparison of the Number of Visits and the Quality of Life Versus Natural Cycle in Stimulated Cycle Before Frozen Embryo Transfer
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug, Other
Study Phase: Phase 4
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
Enrollment Status: Terminated
Publish Date: June 16, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Phase 4
View 5 Less Clinical Trials

32 Total Publications

Outcomes of frozen embryo transfers from a large monocentric cohort (2982 cycles): towards a preferential use of cycles with a corpus luteum for endometrial preparation.
Outcomes of frozen embryo transfers from a large monocentric cohort (2982 cycles): towards a preferential use of cycles with a corpus luteum for endometrial preparation.
Journal: Frontiers in endocrinology
Published: February 10, 2026

Frequently Asked Questions about Nathalie Massin

Is Nathalie Massin a top-rated expert for Ovarian Hyperstimulation Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Nathalie Massin is classified as an Advanced expert for Ovarian Hyperstimulation Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nathalie Massin participate in research or clinical trials?

Yes. Nathalie Massin has published 32 articles and abstracts on conditions like Ovarian Hyperstimulation Syndrome. You can view a list of Nathalie Massin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Massin's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile